Craig Stuart Millian, Chief Commercial Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 5,000 shares at $6.85 ($34K) on 2019-03-14, disclosed to the SEC on 2019-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CRBP | BUY | 2020-03-18 | $9K | — | Filing → |
| CRBP | BUY | 2019-11-12 | $4K | — | Filing → |
| CRBP | BUY | 2019-08-16 | $8K | — | Filing → |